0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Chemical Medication in COVID-19 Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-5G5927
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Chemical Medication in COVID 19 Market Insights Forecast to 2028
BUY CHAPTERS

Global Chemical Medication in COVID-19 Market Research Report 2025

Code: QYRE-Auto-5G5927
Report
July 2025
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Chemical Medication in COVID-19 Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Chemical Medication in COVID-19 Market

Chemical Medication in COVID-19 Market

The global market for Chemical Medication in COVID-19 was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
According to China"s clinical trials of COVID-19 treatment, the most clinically tested varieties are chemical drugs, especially chloroquine and antiviral drugs. Due to effective control, the proportion of clinical trials in China has been greatly reduced. Among the chemical drug clinical projects, chloroquine accounted for the largest proportion, followed by ritonavir、lopinavir and ridacive.
This report focuses on the investigation and analysis of chemical medication in COVID-19 and predicts the future market development of biopharmaceuticals under the influence of COVID-19.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Chemical Medication in COVID-19, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chemical Medication in COVID-19.
The Chemical Medication in COVID-19 market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chemical Medication in COVID-19 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chemical Medication in COVID-19 companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Chemical Medication in COVID-19 Market Report

Report Metric Details
Report Name Chemical Medication in COVID-19 Market
CAGR 5%
Segment by Type
Segment by Application
  • COVID-19
  • Influenza
  • Malaria
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Gilead Sciences, AbbVie, Johnson & Johnson, Pfizer, Mylan, Bayer, Zhejiang Hisun, CSPC Pharmaceutical Group, Reyoung Pharmaceutical, Sihuan Pharmaceutical, Hikma Pharmaceuticals, Rising Pharmaceutical, Sun Pharma, Shanghai Pharma, Guangzhou Baiyunshan Guanghua Pharmaceutical, KPC Group, Jinghua Pharmaceutical Group, Zhongsheng Pharma, North China Pharmaceutical Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Chemical Medication in COVID-19 company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Chemical Medication in COVID-19 Market report?

Ans: The main players in the Chemical Medication in COVID-19 Market are Gilead Sciences, AbbVie, Johnson & Johnson, Pfizer, Mylan, Bayer, Zhejiang Hisun, CSPC Pharmaceutical Group, Reyoung Pharmaceutical, Sihuan Pharmaceutical, Hikma Pharmaceuticals, Rising Pharmaceutical, Sun Pharma, Shanghai Pharma, Guangzhou Baiyunshan Guanghua Pharmaceutical, KPC Group, Jinghua Pharmaceutical Group, Zhongsheng Pharma, North China Pharmaceutical Group

What are the Application segmentation covered in the Chemical Medication in COVID-19 Market report?

Ans: The Applications covered in the Chemical Medication in COVID-19 Market report are COVID-19, Influenza, Malaria, Others

What are the Type segmentation covered in the Chemical Medication in COVID-19 Market report?

Ans: The Types covered in the Chemical Medication in COVID-19 Market report are Remedsivir, Ardidol, Favipivir, Lopinavir/ritonavir (LPV/r), Chloroquine, Others

Recommended Reports

COVID-19 Related Drugs

COVID-19 Vaccines and Logistics

Disease Diagnostics and Testing

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chemical Medication in COVID-19 Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Remedsivir
1.2.3 Ardidol
1.2.4 Favipivir
1.2.5 Lopinavir/ritonavir (LPV/r)
1.2.6 Chloroquine
1.2.7 Others
1.3 Market by Application
1.3.1 Global Chemical Medication in COVID-19 Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 COVID-19
1.3.3 Influenza
1.3.4 Malaria
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chemical Medication in COVID-19 Market Perspective (2020-2031)
2.2 Global Chemical Medication in COVID-19 Growth Trends by Region
2.2.1 Global Chemical Medication in COVID-19 Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Chemical Medication in COVID-19 Historic Market Size by Region (2020-2025)
2.2.3 Chemical Medication in COVID-19 Forecasted Market Size by Region (2026-2031)
2.3 Chemical Medication in COVID-19 Market Dynamics
2.3.1 Chemical Medication in COVID-19 Industry Trends
2.3.2 Chemical Medication in COVID-19 Market Drivers
2.3.3 Chemical Medication in COVID-19 Market Challenges
2.3.4 Chemical Medication in COVID-19 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chemical Medication in COVID-19 Players by Revenue
3.1.1 Global Top Chemical Medication in COVID-19 Players by Revenue (2020-2025)
3.1.2 Global Chemical Medication in COVID-19 Revenue Market Share by Players (2020-2025)
3.2 Global Chemical Medication in COVID-19 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Chemical Medication in COVID-19 Revenue
3.4 Global Chemical Medication in COVID-19 Market Concentration Ratio
3.4.1 Global Chemical Medication in COVID-19 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chemical Medication in COVID-19 Revenue in 2024
3.5 Global Key Players of Chemical Medication in COVID-19 Head office and Area Served
3.6 Global Key Players of Chemical Medication in COVID-19, Product and Application
3.7 Global Key Players of Chemical Medication in COVID-19, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Chemical Medication in COVID-19 Breakdown Data by Type
4.1 Global Chemical Medication in COVID-19 Historic Market Size by Type (2020-2025)
4.2 Global Chemical Medication in COVID-19 Forecasted Market Size by Type (2026-2031)
5 Chemical Medication in COVID-19 Breakdown Data by Application
5.1 Global Chemical Medication in COVID-19 Historic Market Size by Application (2020-2025)
5.2 Global Chemical Medication in COVID-19 Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Chemical Medication in COVID-19 Market Size (2020-2031)
6.2 North America Chemical Medication in COVID-19 Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Chemical Medication in COVID-19 Market Size by Country (2020-2025)
6.4 North America Chemical Medication in COVID-19 Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chemical Medication in COVID-19 Market Size (2020-2031)
7.2 Europe Chemical Medication in COVID-19 Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Chemical Medication in COVID-19 Market Size by Country (2020-2025)
7.4 Europe Chemical Medication in COVID-19 Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chemical Medication in COVID-19 Market Size (2020-2031)
8.2 Asia-Pacific Chemical Medication in COVID-19 Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Chemical Medication in COVID-19 Market Size by Region (2020-2025)
8.4 Asia-Pacific Chemical Medication in COVID-19 Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chemical Medication in COVID-19 Market Size (2020-2031)
9.2 Latin America Chemical Medication in COVID-19 Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Chemical Medication in COVID-19 Market Size by Country (2020-2025)
9.4 Latin America Chemical Medication in COVID-19 Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chemical Medication in COVID-19 Market Size (2020-2031)
10.2 Middle East & Africa Chemical Medication in COVID-19 Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Chemical Medication in COVID-19 Market Size by Country (2020-2025)
10.4 Middle East & Africa Chemical Medication in COVID-19 Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Details
11.1.2 Gilead Sciences Business Overview
11.1.3 Gilead Sciences Chemical Medication in COVID-19 Introduction
11.1.4 Gilead Sciences Revenue in Chemical Medication in COVID-19 Business (2020-2025)
11.1.5 Gilead Sciences Recent Development
11.2 AbbVie
11.2.1 AbbVie Company Details
11.2.2 AbbVie Business Overview
11.2.3 AbbVie Chemical Medication in COVID-19 Introduction
11.2.4 AbbVie Revenue in Chemical Medication in COVID-19 Business (2020-2025)
11.2.5 AbbVie Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Chemical Medication in COVID-19 Introduction
11.3.4 Johnson & Johnson Revenue in Chemical Medication in COVID-19 Business (2020-2025)
11.3.5 Johnson & Johnson Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Chemical Medication in COVID-19 Introduction
11.4.4 Pfizer Revenue in Chemical Medication in COVID-19 Business (2020-2025)
11.4.5 Pfizer Recent Development
11.5 Mylan
11.5.1 Mylan Company Details
11.5.2 Mylan Business Overview
11.5.3 Mylan Chemical Medication in COVID-19 Introduction
11.5.4 Mylan Revenue in Chemical Medication in COVID-19 Business (2020-2025)
11.5.5 Mylan Recent Development
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Chemical Medication in COVID-19 Introduction
11.6.4 Bayer Revenue in Chemical Medication in COVID-19 Business (2020-2025)
11.6.5 Bayer Recent Development
11.7 Zhejiang Hisun
11.7.1 Zhejiang Hisun Company Details
11.7.2 Zhejiang Hisun Business Overview
11.7.3 Zhejiang Hisun Chemical Medication in COVID-19 Introduction
11.7.4 Zhejiang Hisun Revenue in Chemical Medication in COVID-19 Business (2020-2025)
11.7.5 Zhejiang Hisun Recent Development
11.8 CSPC Pharmaceutical Group
11.8.1 CSPC Pharmaceutical Group Company Details
11.8.2 CSPC Pharmaceutical Group Business Overview
11.8.3 CSPC Pharmaceutical Group Chemical Medication in COVID-19 Introduction
11.8.4 CSPC Pharmaceutical Group Revenue in Chemical Medication in COVID-19 Business (2020-2025)
11.8.5 CSPC Pharmaceutical Group Recent Development
11.9 Reyoung Pharmaceutical
11.9.1 Reyoung Pharmaceutical Company Details
11.9.2 Reyoung Pharmaceutical Business Overview
11.9.3 Reyoung Pharmaceutical Chemical Medication in COVID-19 Introduction
11.9.4 Reyoung Pharmaceutical Revenue in Chemical Medication in COVID-19 Business (2020-2025)
11.9.5 Reyoung Pharmaceutical Recent Development
11.10 Sihuan Pharmaceutical
11.10.1 Sihuan Pharmaceutical Company Details
11.10.2 Sihuan Pharmaceutical Business Overview
11.10.3 Sihuan Pharmaceutical Chemical Medication in COVID-19 Introduction
11.10.4 Sihuan Pharmaceutical Revenue in Chemical Medication in COVID-19 Business (2020-2025)
11.10.5 Sihuan Pharmaceutical Recent Development
11.11 Hikma Pharmaceuticals
11.11.1 Hikma Pharmaceuticals Company Details
11.11.2 Hikma Pharmaceuticals Business Overview
11.11.3 Hikma Pharmaceuticals Chemical Medication in COVID-19 Introduction
11.11.4 Hikma Pharmaceuticals Revenue in Chemical Medication in COVID-19 Business (2020-2025)
11.11.5 Hikma Pharmaceuticals Recent Development
11.12 Rising Pharmaceutical
11.12.1 Rising Pharmaceutical Company Details
11.12.2 Rising Pharmaceutical Business Overview
11.12.3 Rising Pharmaceutical Chemical Medication in COVID-19 Introduction
11.12.4 Rising Pharmaceutical Revenue in Chemical Medication in COVID-19 Business (2020-2025)
11.12.5 Rising Pharmaceutical Recent Development
11.13 Sun Pharma
11.13.1 Sun Pharma Company Details
11.13.2 Sun Pharma Business Overview
11.13.3 Sun Pharma Chemical Medication in COVID-19 Introduction
11.13.4 Sun Pharma Revenue in Chemical Medication in COVID-19 Business (2020-2025)
11.13.5 Sun Pharma Recent Development
11.14 Shanghai Pharma
11.14.1 Shanghai Pharma Company Details
11.14.2 Shanghai Pharma Business Overview
11.14.3 Shanghai Pharma Chemical Medication in COVID-19 Introduction
11.14.4 Shanghai Pharma Revenue in Chemical Medication in COVID-19 Business (2020-2025)
11.14.5 Shanghai Pharma Recent Development
11.15 Guangzhou Baiyunshan Guanghua Pharmaceutical
11.15.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Company Details
11.15.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview
11.15.3 Guangzhou Baiyunshan Guanghua Pharmaceutical Chemical Medication in COVID-19 Introduction
11.15.4 Guangzhou Baiyunshan Guanghua Pharmaceutical Revenue in Chemical Medication in COVID-19 Business (2020-2025)
11.15.5 Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Development
11.16 KPC Group
11.16.1 KPC Group Company Details
11.16.2 KPC Group Business Overview
11.16.3 KPC Group Chemical Medication in COVID-19 Introduction
11.16.4 KPC Group Revenue in Chemical Medication in COVID-19 Business (2020-2025)
11.16.5 KPC Group Recent Development
11.17 Jinghua Pharmaceutical Group
11.17.1 Jinghua Pharmaceutical Group Company Details
11.17.2 Jinghua Pharmaceutical Group Business Overview
11.17.3 Jinghua Pharmaceutical Group Chemical Medication in COVID-19 Introduction
11.17.4 Jinghua Pharmaceutical Group Revenue in Chemical Medication in COVID-19 Business (2020-2025)
11.17.5 Jinghua Pharmaceutical Group Recent Development
11.18 Zhongsheng Pharma
11.18.1 Zhongsheng Pharma Company Details
11.18.2 Zhongsheng Pharma Business Overview
11.18.3 Zhongsheng Pharma Chemical Medication in COVID-19 Introduction
11.18.4 Zhongsheng Pharma Revenue in Chemical Medication in COVID-19 Business (2020-2025)
11.18.5 Zhongsheng Pharma Recent Development
11.19 North China Pharmaceutical Group
11.19.1 North China Pharmaceutical Group Company Details
11.19.2 North China Pharmaceutical Group Business Overview
11.19.3 North China Pharmaceutical Group Chemical Medication in COVID-19 Introduction
11.19.4 North China Pharmaceutical Group Revenue in Chemical Medication in COVID-19 Business (2020-2025)
11.19.5 North China Pharmaceutical Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Chemical Medication in COVID-19 Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Remedsivir
 Table 3. Key Players of Ardidol
 Table 4. Key Players of Favipivir
 Table 5. Key Players of Lopinavir/ritonavir (LPV/r)
 Table 6. Key Players of Chloroquine
 Table 7. Key Players of Others
 Table 8. Global Chemical Medication in COVID-19 Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Chemical Medication in COVID-19 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Chemical Medication in COVID-19 Market Size by Region (2020-2025) & (US$ Million)
 Table 11. Global Chemical Medication in COVID-19 Market Share by Region (2020-2025)
 Table 12. Global Chemical Medication in COVID-19 Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 13. Global Chemical Medication in COVID-19 Market Share by Region (2026-2031)
 Table 14. Chemical Medication in COVID-19 Market Trends
 Table 15. Chemical Medication in COVID-19 Market Drivers
 Table 16. Chemical Medication in COVID-19 Market Challenges
 Table 17. Chemical Medication in COVID-19 Market Restraints
 Table 18. Global Chemical Medication in COVID-19 Revenue by Players (2020-2025) & (US$ Million)
 Table 19. Global Chemical Medication in COVID-19 Market Share by Players (2020-2025)
 Table 20. Global Top Chemical Medication in COVID-19 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemical Medication in COVID-19 as of 2024)
 Table 21. Ranking of Global Top Chemical Medication in COVID-19 Companies by Revenue (US$ Million) in 2024
 Table 22. Global 5 Largest Players Market Share by Chemical Medication in COVID-19 Revenue (CR5 and HHI) & (2020-2025)
 Table 23. Global Key Players of Chemical Medication in COVID-19, Headquarters and Area Served
 Table 24. Global Key Players of Chemical Medication in COVID-19, Product and Application
 Table 25. Global Key Players of Chemical Medication in COVID-19, Date of Enter into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. Global Chemical Medication in COVID-19 Market Size by Type (2020-2025) & (US$ Million)
 Table 28. Global Chemical Medication in COVID-19 Revenue Market Share by Type (2020-2025)
 Table 29. Global Chemical Medication in COVID-19 Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 30. Global Chemical Medication in COVID-19 Revenue Market Share by Type (2026-2031)
 Table 31. Global Chemical Medication in COVID-19 Market Size by Application (2020-2025) & (US$ Million)
 Table 32. Global Chemical Medication in COVID-19 Revenue Market Share by Application (2020-2025)
 Table 33. Global Chemical Medication in COVID-19 Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 34. Global Chemical Medication in COVID-19 Revenue Market Share by Application (2026-2031)
 Table 35. North America Chemical Medication in COVID-19 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. North America Chemical Medication in COVID-19 Market Size by Country (2020-2025) & (US$ Million)
 Table 37. North America Chemical Medication in COVID-19 Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Europe Chemical Medication in COVID-19 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Europe Chemical Medication in COVID-19 Market Size by Country (2020-2025) & (US$ Million)
 Table 40. Europe Chemical Medication in COVID-19 Market Size by Country (2026-2031) & (US$ Million)
 Table 41. Asia-Pacific Chemical Medication in COVID-19 Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Asia-Pacific Chemical Medication in COVID-19 Market Size by Region (2020-2025) & (US$ Million)
 Table 43. Asia-Pacific Chemical Medication in COVID-19 Market Size by Region (2026-2031) & (US$ Million)
 Table 44. Latin America Chemical Medication in COVID-19 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Latin America Chemical Medication in COVID-19 Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Latin America Chemical Medication in COVID-19 Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Middle East & Africa Chemical Medication in COVID-19 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 48. Middle East & Africa Chemical Medication in COVID-19 Market Size by Country (2020-2025) & (US$ Million)
 Table 49. Middle East & Africa Chemical Medication in COVID-19 Market Size by Country (2026-2031) & (US$ Million)
 Table 50. Gilead Sciences Company Details
 Table 51. Gilead Sciences Business Overview
 Table 52. Gilead Sciences Chemical Medication in COVID-19 Product
 Table 53. Gilead Sciences Revenue in Chemical Medication in COVID-19 Business (2020-2025) & (US$ Million)
 Table 54. Gilead Sciences Recent Development
 Table 55. AbbVie Company Details
 Table 56. AbbVie Business Overview
 Table 57. AbbVie Chemical Medication in COVID-19 Product
 Table 58. AbbVie Revenue in Chemical Medication in COVID-19 Business (2020-2025) & (US$ Million)
 Table 59. AbbVie Recent Development
 Table 60. Johnson & Johnson Company Details
 Table 61. Johnson & Johnson Business Overview
 Table 62. Johnson & Johnson Chemical Medication in COVID-19 Product
 Table 63. Johnson & Johnson Revenue in Chemical Medication in COVID-19 Business (2020-2025) & (US$ Million)
 Table 64. Johnson & Johnson Recent Development
 Table 65. Pfizer Company Details
 Table 66. Pfizer Business Overview
 Table 67. Pfizer Chemical Medication in COVID-19 Product
 Table 68. Pfizer Revenue in Chemical Medication in COVID-19 Business (2020-2025) & (US$ Million)
 Table 69. Pfizer Recent Development
 Table 70. Mylan Company Details
 Table 71. Mylan Business Overview
 Table 72. Mylan Chemical Medication in COVID-19 Product
 Table 73. Mylan Revenue in Chemical Medication in COVID-19 Business (2020-2025) & (US$ Million)
 Table 74. Mylan Recent Development
 Table 75. Bayer Company Details
 Table 76. Bayer Business Overview
 Table 77. Bayer Chemical Medication in COVID-19 Product
 Table 78. Bayer Revenue in Chemical Medication in COVID-19 Business (2020-2025) & (US$ Million)
 Table 79. Bayer Recent Development
 Table 80. Zhejiang Hisun Company Details
 Table 81. Zhejiang Hisun Business Overview
 Table 82. Zhejiang Hisun Chemical Medication in COVID-19 Product
 Table 83. Zhejiang Hisun Revenue in Chemical Medication in COVID-19 Business (2020-2025) & (US$ Million)
 Table 84. Zhejiang Hisun Recent Development
 Table 85. CSPC Pharmaceutical Group Company Details
 Table 86. CSPC Pharmaceutical Group Business Overview
 Table 87. CSPC Pharmaceutical Group Chemical Medication in COVID-19 Product
 Table 88. CSPC Pharmaceutical Group Revenue in Chemical Medication in COVID-19 Business (2020-2025) & (US$ Million)
 Table 89. CSPC Pharmaceutical Group Recent Development
 Table 90. Reyoung Pharmaceutical Company Details
 Table 91. Reyoung Pharmaceutical Business Overview
 Table 92. Reyoung Pharmaceutical Chemical Medication in COVID-19 Product
 Table 93. Reyoung Pharmaceutical Revenue in Chemical Medication in COVID-19 Business (2020-2025) & (US$ Million)
 Table 94. Reyoung Pharmaceutical Recent Development
 Table 95. Sihuan Pharmaceutical Company Details
 Table 96. Sihuan Pharmaceutical Business Overview
 Table 97. Sihuan Pharmaceutical Chemical Medication in COVID-19 Product
 Table 98. Sihuan Pharmaceutical Revenue in Chemical Medication in COVID-19 Business (2020-2025) & (US$ Million)
 Table 99. Sihuan Pharmaceutical Recent Development
 Table 100. Hikma Pharmaceuticals Company Details
 Table 101. Hikma Pharmaceuticals Business Overview
 Table 102. Hikma Pharmaceuticals Chemical Medication in COVID-19 Product
 Table 103. Hikma Pharmaceuticals Revenue in Chemical Medication in COVID-19 Business (2020-2025) & (US$ Million)
 Table 104. Hikma Pharmaceuticals Recent Development
 Table 105. Rising Pharmaceutical Company Details
 Table 106. Rising Pharmaceutical Business Overview
 Table 107. Rising Pharmaceutical Chemical Medication in COVID-19 Product
 Table 108. Rising Pharmaceutical Revenue in Chemical Medication in COVID-19 Business (2020-2025) & (US$ Million)
 Table 109. Rising Pharmaceutical Recent Development
 Table 110. Sun Pharma Company Details
 Table 111. Sun Pharma Business Overview
 Table 112. Sun Pharma Chemical Medication in COVID-19 Product
 Table 113. Sun Pharma Revenue in Chemical Medication in COVID-19 Business (2020-2025) & (US$ Million)
 Table 114. Sun Pharma Recent Development
 Table 115. Shanghai Pharma Company Details
 Table 116. Shanghai Pharma Business Overview
 Table 117. Shanghai Pharma Chemical Medication in COVID-19 Product
 Table 118. Shanghai Pharma Revenue in Chemical Medication in COVID-19 Business (2020-2025) & (US$ Million)
 Table 119. Shanghai Pharma Recent Development
 Table 120. Guangzhou Baiyunshan Guanghua Pharmaceutical Company Details
 Table 121. Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview
 Table 122. Guangzhou Baiyunshan Guanghua Pharmaceutical Chemical Medication in COVID-19 Product
 Table 123. Guangzhou Baiyunshan Guanghua Pharmaceutical Revenue in Chemical Medication in COVID-19 Business (2020-2025) & (US$ Million)
 Table 124. Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Development
 Table 125. KPC Group Company Details
 Table 126. KPC Group Business Overview
 Table 127. KPC Group Chemical Medication in COVID-19 Product
 Table 128. KPC Group Revenue in Chemical Medication in COVID-19 Business (2020-2025) & (US$ Million)
 Table 129. KPC Group Recent Development
 Table 130. Jinghua Pharmaceutical Group Company Details
 Table 131. Jinghua Pharmaceutical Group Business Overview
 Table 132. Jinghua Pharmaceutical Group Chemical Medication in COVID-19 Product
 Table 133. Jinghua Pharmaceutical Group Revenue in Chemical Medication in COVID-19 Business (2020-2025) & (US$ Million)
 Table 134. Jinghua Pharmaceutical Group Recent Development
 Table 135. Zhongsheng Pharma Company Details
 Table 136. Zhongsheng Pharma Business Overview
 Table 137. Zhongsheng Pharma Chemical Medication in COVID-19 Product
 Table 138. Zhongsheng Pharma Revenue in Chemical Medication in COVID-19 Business (2020-2025) & (US$ Million)
 Table 139. Zhongsheng Pharma Recent Development
 Table 140. North China Pharmaceutical Group Company Details
 Table 141. North China Pharmaceutical Group Business Overview
 Table 142. North China Pharmaceutical Group Chemical Medication in COVID-19 Product
 Table 143. North China Pharmaceutical Group Revenue in Chemical Medication in COVID-19 Business (2020-2025) & (US$ Million)
 Table 144. North China Pharmaceutical Group Recent Development
 Table 145. Research Programs/Design for This Report
 Table 146. Key Data Information from Secondary Sources
 Table 147. Key Data Information from Primary Sources
 Table 148. Authors List of This Report


List of Figures
 Figure 1. Chemical Medication in COVID-19 Picture
 Figure 2. Global Chemical Medication in COVID-19 Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Chemical Medication in COVID-19 Market Share by Type: 2024 VS 2031
 Figure 4. Remedsivir Features
 Figure 5. Ardidol Features
 Figure 6. Favipivir Features
 Figure 7. Lopinavir/ritonavir (LPV/r) Features
 Figure 8. Chloroquine Features
 Figure 9. Others Features
 Figure 10. Global Chemical Medication in COVID-19 Market Size by Application (2020-2031) & (US$ Million)
 Figure 11. Global Chemical Medication in COVID-19 Market Share by Application: 2024 VS 2031
 Figure 12. COVID-19 Case Studies
 Figure 13. Influenza Case Studies
 Figure 14. Malaria Case Studies
 Figure 15. Others Case Studies
 Figure 16. Chemical Medication in COVID-19 Report Years Considered
 Figure 17. Global Chemical Medication in COVID-19 Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 18. Global Chemical Medication in COVID-19 Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Chemical Medication in COVID-19 Market Share by Region: 2024 VS 2031
 Figure 20. Global Chemical Medication in COVID-19 Market Share by Players in 2024
 Figure 21. Global Top Chemical Medication in COVID-19 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemical Medication in COVID-19 as of 2024)
 Figure 22. The Top 10 and 5 Players Market Share by Chemical Medication in COVID-19 Revenue in 2024
 Figure 23. North America Chemical Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. North America Chemical Medication in COVID-19 Market Share by Country (2020-2031)
 Figure 25. United States Chemical Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Canada Chemical Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Chemical Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Chemical Medication in COVID-19 Market Share by Country (2020-2031)
 Figure 29. Germany Chemical Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. France Chemical Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. U.K. Chemical Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Italy Chemical Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Russia Chemical Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Nordic Countries Chemical Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Chemical Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Chemical Medication in COVID-19 Market Share by Region (2020-2031)
 Figure 37. China Chemical Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Japan Chemical Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. South Korea Chemical Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Chemical Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. India Chemical Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Australia Chemical Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Chemical Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Chemical Medication in COVID-19 Market Share by Country (2020-2031)
 Figure 45. Mexico Chemical Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Brazil Chemical Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Chemical Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Chemical Medication in COVID-19 Market Share by Country (2020-2031)
 Figure 49. Turkey Chemical Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Chemical Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. UAE Chemical Medication in COVID-19 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Gilead Sciences Revenue Growth Rate in Chemical Medication in COVID-19 Business (2020-2025)
 Figure 53. AbbVie Revenue Growth Rate in Chemical Medication in COVID-19 Business (2020-2025)
 Figure 54. Johnson & Johnson Revenue Growth Rate in Chemical Medication in COVID-19 Business (2020-2025)
 Figure 55. Pfizer Revenue Growth Rate in Chemical Medication in COVID-19 Business (2020-2025)
 Figure 56. Mylan Revenue Growth Rate in Chemical Medication in COVID-19 Business (2020-2025)
 Figure 57. Bayer Revenue Growth Rate in Chemical Medication in COVID-19 Business (2020-2025)
 Figure 58. Zhejiang Hisun Revenue Growth Rate in Chemical Medication in COVID-19 Business (2020-2025)
 Figure 59. CSPC Pharmaceutical Group Revenue Growth Rate in Chemical Medication in COVID-19 Business (2020-2025)
 Figure 60. Reyoung Pharmaceutical Revenue Growth Rate in Chemical Medication in COVID-19 Business (2020-2025)
 Figure 61. Sihuan Pharmaceutical Revenue Growth Rate in Chemical Medication in COVID-19 Business (2020-2025)
 Figure 62. Hikma Pharmaceuticals Revenue Growth Rate in Chemical Medication in COVID-19 Business (2020-2025)
 Figure 63. Rising Pharmaceutical Revenue Growth Rate in Chemical Medication in COVID-19 Business (2020-2025)
 Figure 64. Sun Pharma Revenue Growth Rate in Chemical Medication in COVID-19 Business (2020-2025)
 Figure 65. Shanghai Pharma Revenue Growth Rate in Chemical Medication in COVID-19 Business (2020-2025)
 Figure 66. Guangzhou Baiyunshan Guanghua Pharmaceutical Revenue Growth Rate in Chemical Medication in COVID-19 Business (2020-2025)
 Figure 67. KPC Group Revenue Growth Rate in Chemical Medication in COVID-19 Business (2020-2025)
 Figure 68. Jinghua Pharmaceutical Group Revenue Growth Rate in Chemical Medication in COVID-19 Business (2020-2025)
 Figure 69. Zhongsheng Pharma Revenue Growth Rate in Chemical Medication in COVID-19 Business (2020-2025)
 Figure 70. North China Pharmaceutical Group Revenue Growth Rate in Chemical Medication in COVID-19 Business (2020-2025)
 Figure 71. Bottom-up and Top-down Approaches for This Report
 Figure 72. Data Triangulation
 Figure 73. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS